no published inhibition or induction data Primary clinical concern / increased bleeding risk from additive vascular and hemostatic effects Severity estimate / moderate (theoretical), based on pharmacodynamic reasoning Monitoring needed / CBC with platelets, PT/INR, anti-Factor Xa levels, signs of bleeding Dose adjustment / no validated protocol exists
Its a small tripeptide bound to a copper ion, and it was first identified in human plasma decades ago
Goeke, J.E., Kist, S., Schubert, S., Hickel, R., Huth, K.C., and Kollmuss, M., Clin
How long can a reconstituted peptide solution prepared with BAC water be stored in laboratory conditions
FOR RESEARCH USE ONLY.
Your path to recovery begins here at Regenerative Medicine LA